Clinical Trial on Moderate to Severe Atopic Dermatitis

Click here to Register


A local research facility is seeking participants for a clinical research study on moderate-to-severe atopic dermatitis. The purpose of this clinical study is to assess the immune response to 2 different approved vaccines after receiving an investigational injectable medication for atopic dermatitis.

Qualified candidates receive no-cost medication, study-related care and are eligible for financial compensation.

Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.

Other focus groups: